UPT Perpustakaan Universitas Andalas
Repositori PerpustakaanUniversitas Andalas
 

INDEKS MASSA TUBUH SEBAGAI FAKTOR PROGNOSTIK PADA KANKER PAYUDARA OPERABEL DI KOTA PADANG

dc.contributor.authorTondy, Arian Pakpahan
dc.date.accessioned2026-09-24T17:59:10Z
dc.date.issued2020-11-17
dc.descriptionDr. dr. Wirsma Arif Harahap, SpB(K)Onk
dc.description.abstractLatar belakang dan tujuan. Kanker payudara (KPD) merupakan penyakit keganasan terbanyak dan penyebab kematian terbanyak pada perempuan di seluruh dunia. Kejadian dan prognosis KPD berhubungan dengan indeks masa tubuh (IMT). Penulis ingin mengetahui apakah IMT dapat dijadikan faktor prognostik terhadap KPD operabel di Padang. Metoda. Penelitian ini menggunakan metode retrospective cross-sectional. Data diambil dari data PERABOI, pasien yang berobat di beberapa rumah sakit di Padang dari Januari 2011 sampai Desember 2015. Analisis menggunakan Chi-Square dan Fischer, melibatkan faktor prognostik lainnya. Hasil. Dari 97 sampel di dapatkan kejadian KPD lebih banyak terjadi pada IMT tinggi (IMT ≥23, standar Kementrian Kesehatan Indonesia) sebanyak 57 sampel (58,8%). Secara langsung IMT tidak memiliki hubungan bermakna dengan rekurensi (p=0,815). Angka kematian meningkat pada IMT tinggi (43,9%) dibanding normal (30,0%) namun tidak bermakna secara statistik (p=0,205). Mortalitas meningkat pada kelompok stadium IIIa (p=0,039) dan status kelenjar getah bening (KGB) aksila N1 (p=0,009). Rekurensi meningkat pada kelompok status KGB axilla N1 (p=0,035). Kesimpulan. Secara langsung IMT tidak memiliki hubungan bermakna terhadap rekurensi (p=0,815) dan mortalitas(p=0,205). IMT mempengaruhi mortalitas pada kelompok stadium IIIa (p=0,039) dan status KGB aksila N1 (p=0,009). IMT mempengaruhi rekurensi pada kelompok status KGB aksila N1 (p=0,035).
dc.identifier.urihttps://ailib.my.id/handle/123456789/8923
dc.language.isoid
dc.publisherUniversitas Andalas
dc.subjectKanker payudara
dc.subjectIndeks Masa Tubuh
dc.subjectFaktor prognostik
dc.subjectRekurensi
dc.subjectMortalitas
dc.subject.classificationSF Animal culture
dc.titleINDEKS MASSA TUBUH SEBAGAI FAKTOR PROGNOSTIK PADA KANKER PAYUDARA OPERABEL DI KOTA PADANG
dc.typeThesis
dcterms.dateSubmitted2021-01-22
dcterms.references1. Globocan Observatory W. Cancer Today - World. Int Agency Res Cancer [Internet].2019;876:2018–9.Availablefrom: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. (diakses 25 Desember 2019) 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan;69(1):7-34.doi: 10.3322/caac.21551. Epub 2019 Jan 8.(diakses 25 Desember 2019) 3. The Global Cancer Observatory. Malaysia-Cancer fact sheet. World Health Organization 2019; 593: 1–2. (diakses 25 Desember 2019) 4. The Global Cancer Observatory. China-Cancer fact sheet. World Health Organization 2018 (diakses 25 Desember 2019) 5. The Global Cancer Observatory. Malaysia-Cancer fact sheet. World Health Organization 2019; 593: 1–2. 6. Country-specific I, Method N, Country-specific M. 266 794 986. 2019;256:2018–9. 7. Kementerian Kesehatan. Pokok-pokok Hasil Riskesdas 2018. Badan Litbang Kesehatan. Jakarta (ID): 2019. 8. Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, et al. Articles Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. 2016 [cited 2020 Jun 4]; Available from http://dx.doi.org/10.1016/Sun L, Zhu Y, Qian Q, Tang L. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis. Medicine (Baltimore) 2018;97(26):e11220. 9. Sun L, Zhu Y, Qian Q, Tang L. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis. Medicine(Baltimore)2018;97(26):e11220.2018.doi:10.1097/MD.0000000000 011220.(diakses 25 Desember 2019) 10. Roy SS, Vadlamudi RK. Role of Estrogen Receptor Signaling in Breast Cancer Metastasis. 2012;2012. 654698.DOI: 10.1155/2012/654698. Epub 2011 Dec 19. (diakses 25 Desember 2019) 11. Manavathi B, Dey O, Narsihma V, Gajulapalli R, Bhatia RS, Bugide S, et al. Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple. 2012;33(December):1–31. 2013 Feb;34(1):1-32. DOI: 10.1210/er.2011-1057. Epub 2012 Sep 4.(diakses 25 Desember 2019) 12. Cleary MP, Grossmann ME. Minireview : Obesity and Breast Cancer : The Estrogen Connection. 2015;150(January):2537–42. 2009 Jun;150(6):2537-42. DOI: 10.1210/en.2009-0070.(diakses 25 Desember 2019) 13. Liu K, Zhang W, Dai Z, et al. Association between body mass index and breast cancer risk: evidence based on a dose-response meta-analysis. Cancer Manag Res 2018; 10: 143–151. Published 2018 Jan 18. DOI: 10.2147/CMAR.S144619. eCollection 2018. 14. Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis. J Natl Cancer Inst. 2015; 107(12): djv275. Published 2015 Sep 30. DOI: 10.1093/jnci/djv275.(diakses 25 Desember 2019) 15. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst. 1996; 88(11): 756–8. Epub 1996/06/05. pmid:8637031. 16. AllenNE Appleby PN Kaaks R Rinaldi S Davey GK & Key TJ. Lifestyle determinants of serum insulin-like growth factor-I (IGF-I) C-peptide and hormone-binding protein levels in British women. Cancer Causes Control 2003, 1465–74. DOI: 10.1023/a:1022518321634.(diakses 25 Desember 2019) 17. KimHS Ingermann AR Tsubaki J Twigg SM Walker GE & Oh Y Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Research 2004, 642229–2237. DOI: 10.1158/0008-5472.can-03-1675.(diakses 25 Desember 2019) 18. Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis. J Natl Cancer Inst. 2015; 107(12): djv275. Published 2015 Sep 30. DOI: 10.1093/jnci/djv275. 19. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst. 1996; 88(11): 756–8. Epub 1996/06/05. pmid:8637031. 20. Globocan Observatory W. Cancer Today - World. Int Agency Res Cancer [Internet]. 2019;876:2018–9. Available from: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. (diakses 25 Desember 2019) 21. Shenvkier T, Weir L, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: Treatment for women with stage III or locally advanced breast cancer. CAMJ 2004; 70: 983-94. DOI: 10.1503/cmaj.1030944. 22. Harahap WA. Pembedahan Pada Tumor Ganas Payudara. Maj Kedokt Andalas.2015;38:57.http://jurnalmka.fk.unand.ac.id/index.php/art/article/viw/ 267 23. Kesehatan K, Penanggulangan K, Nasional K. KANKER PAYUDARA. 24. Gradishar WJ, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, et al. NCCN Guidelines Version 3.2019 Breast Cancer NCCN Guidelines Panel Disclosures. 2019; DOI: 10.6004/jnccn.2019.0009. 25. Athoillah s, Prihartono NA, Gautama W. Pengaruh Indeks Massa Tubuh terhadap Kanker Payudara di Rumah Sakit Kanker Disease-Free Survival Lima Tahun Pasien “Dharmais” Jakarta. Indones J Cancer [Internet]. 2016;10(1):19–28. Available from: https://media.neliti.com/media/publications/63482-ID-pengaruh-indeks massa-tubuh-terhadap-dis.pdf(diakses 25 Desember 2019) 26. Laudisio D, Muscogiuri G, Barrea L, Savastano S, Colao A. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives. Eur J Obstet Gynecol Reprod Biol. 2018 Nov 1;230:217–21. 27. Andò S, Gelsomino L, Panza S, Giordano C, Bonofiglio D, Barone I, et al. Obesity, leptin, and breast cancer: Epidemiological evidence and proposed mechanisms [Internet]. Vol. 11, Cancers. MDPI AG; 2019 [cited 2020 Jun 29].p.62.Availablefrom: https://www.mdpi.com/2072-6694/11/1/62/htm (diakses 25 Desember 2019) 28. Blair CK, Wiggins CL, Nibbe AM, Storlie CB, Prossnitz ER, Royce M, et al. Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics. npj Breast Cancer [Internet]. 2019 Dec 1 [cited 2020 Jun 29];5(1):1–7. Available from: https://www.nature.com/articles/s41523-019-0128-4(diakses 25 Desember 2019) 29. Gennari A, Amadori D, Scarpi E, Farolfi A, Paradiso A, Mangia A, et al. Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy. Breast Cancer Res Treat [Internet]. 2016 Aug 1 [cited 2020 Jun 29];159(1):79–86. Available from: https://pubmed.ncbi.nlm.nih.gov/27460638/(diakses 25 Desember 2019) 30. Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death, and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies [Internet]. Vol. 54, Acta Oncologica. Informa Healthcare; 2015 [cited 2020 Jun 29]. p. 635–54. Available from: http://www.tandfonline.com/doi/full/10.3109/0284186X.2014.998275(diakse s 25 Desember 2019) 31. Vidyadhar Takalkar U, Review M. Edition 1 | Article 1011 ScienceForecast Publications LLC., | Prognostic Indicators in Breast Cancer Patients. J Cancer Res Forecast [Internet]. 2018 [cited 2020 Jun 29];1(1):1011. Available from: https://scienceforecastoa.com/(diakses 25 Desember 2019) 32. Bostwick DG, Grignon DJ, Hammond MEH, Amin MB, Cohen M, Crawford D, et al. Prognostic factors in prostate cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):995–1000. 33. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980 : systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9 · 1 million participants. Lancet [Internet]. 1980;377(9765):557–67. Available from: http://dx.doi.org/10.1016/S0140-6736(10)62037-(diakses 25 Desember 2019) 34. Kementerian Kesehatan. Pokok-pokok Hasil Riskesdas 2018. Badan Litbang Kesehatan. Jakarta (ID): 2019. 35. Brown J, Ligibel J. The Relationship between Obesity and Cancer. American College of Cardiology: 2016. Dipublikasikan tanggal 10/05. Available : https://www.acc.org/latest-in-cardiology/articles/2016/10/06/10/05/the relationship-between-obesity-and-cancer (diakses 25 Desember 2019) 36. Ceschi M, Gutzwillerb F, Mochc H, Eichholzerb M, Probst-Hensch NM. Epidemiology and pathophysiology of obesity as a cause of cancer. Swiss Med Weekly: 2007; 137:50–56. 37. Lee K, Kruper L, Diell – Conwright CM, Mortimer JE. The Impact of Obesity on Breast Cancer Diagnosis and Treatment. Current Oncology Report. 2019; 21: 41. PMID: 17299670 38. Pérez-Hernández , Victoria Catalán, et al. Mechanisms linking excess adiposity and carcinogenesis promotion. Frontier Of Endocrinology. 2014; 5: 65. doi: 10.3389/fendo.2014.00065. 39. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001; 60:91–106. DOI: 10.1079/pns200070. 40. Giovannucci E. Insulin, insulin-like growth factors, and colon cancer: a review of the evidence. J Nutr. 2001;131:3109–20. DOI: 10.1093/jn/131.11.3109S. 41. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531–43. PMID: 12496040 42. Stoll BA. Upper abdominal obesity, insulin resistance, and breast cancer risk. Int J Obes Relat Metab Disord 2002;26:747–53. DOI: 10.1038/sj.ijo.0801998. 43. Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298–302. DOI: 10.1016/s1470-2045(02)00731-3. 44. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am J Med Sci 2002;323:140–5. DOI: 10.1097/00000441-200203000-00004. 45. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: a systematic review and meta-regression analysis. Lancet 2004;363:1346–53. DOI: 10.1016/S0140-6736(04)16044-3. 46. SachdevD & Yee D, The IGF system, and breast cancer. Endocrine-Related Cancer 2001,8197–209. DOI: 10.1677/erc.0.0080197. 47. Zhang X, Yee D. Tyrosine kinase signaling in breast cancer. Insulin-like growth factors and their receptors in breast cancer. Vol. 2, Breast Cancer Research. BioMed Central; 2000. p. 170–5. https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr50 48. KimHS Ingermann AR Tsubaki J Twigg SM Walker GE & Oh Y Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Research 2004, 642229–2237. DOI: 10.1158/0008-5472.can-03-1675. 49. JacksonJG Zhang X Yoneda T & Yee D. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Oncogene 2001, 207318–7325. DOI: 10.1038/sj.onc.1204920. 50. Shimizu Hasegawa T Tani Y Takahashi F Takeuchi M Watanabe T Ando M Katsumata N & Fujiwara Y. Expression of insulin-like growth factor 1 receptor in primary breast cancer: an immunohistochemical analysis. Human Pathology 2004, 351537–1542. DOI: 10.3892/mco.2015.497. 51. Le RoithD. The insulin-like growth factor system. Experimental Diabesity Research 2003, 4205–212. DOI: 10.1155/EDR.2003.205. 52. Sachdev D, Zhang X, Matise I, Gaillard-Kelly M, Yee D. The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene. 2010 Jan;29(2):251–62. DOI: 10.1038/onc.2009.316. Epub 2009 Oct 19. 53. Allen NE Appleby PN Kaaks R Rinaldi S Davey GK & Key TJ. Lifestyle determinants of serum insulin-like growth factor-I (IGF-I) C-peptide and hormone-binding protein levels in British women. Cancer Causes Control 2003, 1465–74. DOI: 10.1023/a:1022518321634. 54. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review. Vol. 11, Cancer Epidemiology Biomarkers and Prevention. American Association for Cancer Research; 2002. p. 1531–43. https://cebp.aacrjournals.org/content/11/12/1531. 55. MutiP Quattrin T Grant BJ Krogh V Micheli A Schunemann HJ Ram M Freudenheim JL Sieri S Trevisan M et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiology Biomarkers & Prevention 2002, 111361–1368. https://pubmed.ncbi.nlm.nih.gov/12433712. 56. ZhangX & Yee D. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. Cancer Research 2002, 624369–4375. https://pubmed.ncbi.nlm.nih.gov/12154042/ 57. Sun Li, Zhu Yulan, Qian Qi, Tang Liming. Body mass index and prognosis of breast cancer.Medicine.2018;97: 26. DOI: 10.1097/MD.0000000000011220 58. Ecker BL, Lee JY, Sterner CJ, et al. Impact of obesity on breast cancer recurrence and minimal residual disease. Breast Cancer Research. 2019; 21: 41. DOI: 10.1186/s13058-018-1087-7. 59. Picon-Ruiz M, Morata-Tarifa M, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and Adverse Breast Cancer Risk and Outcome: Mechanistic Insights and Strategies for Intervention. Ca Cancer J Clin 2017;67:378–397. DOI: 10.3322/caac.21405. Epub 2017 Aug 1. 60. Carmichael AR, Bates T. Obesity, and breast cancer: a review of the literature. The Breast 2004; 13: 85–92. DOI: 10.1016/j.breast.2003.03.001. 61. Jiralerspong S, Goodwin PJ. Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. J Clin Oncol 2016; 34:4203-4216. DOI: 10.1200/JCO.2016.68.4480. Epub 2016 Nov 7. 62. Nattenmüller CJ, Kriegsmann M, Sookthai D, et al. Obesity as a risk factor for subtypes of breast cancer: results from a prospective cohort study. BMC Cancer 2018; 18: 616. DOI: 10.1186/s12885-018-4548-6. 63. Abadi A, Yavari P, Dehghani-Arani M, Alavi-Majd H, Ghasemi E, Amanpour F, et al. Cox models survival analysis based on breast cancer treatments. Iran J Cancer Prev. 2014;7(3):124–9. 64. Bousquenaud M, Fico F, Solinas G, Rüegg C, Santamaria-Martínez A. Obesity promotes the expansion of metastasis-initiating cells in breast cancer. Breast Cancer Res. 2018;20(1):1–11. 65. Furkano V. Hubungan Indeks Massa Tubuh dengan Kejadian Kanker Payudara di RSUP Dr M Djamil Padang [Internet]. Universitas Andalas; 2016. Available from: http://scholar.unand.ac.id/5236/(diakses 25 Desember 2019) 66. Sari SE, Harahap WA, Saputra D. Pengaruh Faktor Risiko Terhadap Ekspresi Reseptor Estrogen Pada Penderita Kanker Payudara Di Kota Padang. J Kesehat Andalas. 2018;7(4):461–8. 67. Amandito R, Viryawan C, Santoso F, Gautami W, Panigoro SS. The Characteristics of Breast Cancer Patients in " Dharmais " Hospital National Cancer Center Jakarta Based on Occupational and Environmental Status. Indones J Cancer [Internet]. 2013;7(2):53–9. Available from: https://media.neliti.com/media/publications/65344-EN-the-characteristics-of- breast-cancer-pat.pdf(diakses 25 Desember 2019) 68. Nindrea RD, Kusnanto H, Haryono SJ, Harahap WA, Dwiprahasto I, Lazuardi L, et al. Development of Breast Cancer Risk Prediction Model for Women in Indonesia: A Case-Control Study. 2020. 1–31 p. 69. Cho WK, Choi DH, Park W, Cha H, Nam SJ, Kim SW, et al. Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment. Clin Breast Cancer [Internet]. 2018;18(5):e1141–7. Available from: https://doi.org/10.1016/j.clbc.2018.04.010(diakses 25 Desember 2019) 70. Chan D.S.M., Viera A.R., Aune D., Bandera E.V., Greenwood D.C., McTiernan A., Rosenblatt D.N., Thune I., Vieira R., Norat T, et al. Body Mass Index and Survival in Women with Breast Cancer - Systematic Literature Review and Meta - Analysis of 82 Follow Up Studies. Annals of Oncology [internet]. 2014;25(10):1901-1914. Available From : https://doi.org/10.1093/annonc/mdu042 (diakses 25 Desember 2019)
local.eprints.dirdisk0/00/06/81/13
local.eprints.division02
local.eprints.id68113
local.eprints.typethesis/masters
local.eprints.urihttp://scholar.unand.ac.id/68113/
local.fakultasFakultas Kedokteran
local.thesis.levelTesis

Files

Collections